...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: Synthesis and anticancer activity
【24h】

Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: Synthesis and anticancer activity

机译:新型吡唑-5-羧酰胺和吡唑-嘧啶衍生物:合成和抗癌活性

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives were designed and synthesized. All compounds have been screened for their antiproliferative activity against MGC-803, SGC-7901 and Bcap-37 cell lines in vitro. The results revealed that compounds 8a, 8c and 8e exhibited strong inhibitory activity against MGC-803 cell line. The flow cytometric analysis result showed that compound 8e could inhibit MGC-803 proliferation. Some title compounds were tested against telomerase, and compound 8e showed the most potent inhibitory activity with IC50 value at 1.02 +/- 0.08 mu M. The docking simulation of compound 8e was performed to get the probable binding model, among them, LYS 189, LYS 372, LYS 249 and ASP 254 may be the key residues for the telomerase activity. (C) 2014 Elsevier Masson SAS. All rights reserved.
机译:设计并合成了一系列新型的吡唑-5-羧酰胺和吡唑-嘧啶衍生物。已经筛选了所有化合物在体外对MGC-803,SGC-7901和Bcap-37细胞系的抗增殖活性。结果表明,化合物8a,8c和8e显示出对MGC-803细胞系的强抑制活性。流式细胞仪分析结果表明,化合物8e可以抑制MGC-803的增殖。测试了一些标题化合物的端粒酶活性,化合物8e表现出最强的抑制活性,IC50值为1.02 +/- 0.08μM。进行了化合物8e的对接模拟,得到了可能的结合模型,其中包括LYS 189, LYS 372,LYS 249和ASP 254可能是端粒酶活性的关键残基。 (C)2014 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号